Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check5 days agoChange DetectedAdded a Locations section listing Texas as a study location. Replaced the old standalone 'Texas Locations' item with the consolidated Locations section.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedMinor editorial wording changes were made to the Publications section to describe automatic PubMed content, and a page revision version notice was updated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedA government funding status notice banner was removed from the page. The change does not alter the study details, eligibility criteria, contact information, or other core content.SummaryDifference0.4%

- Check55 days agoChange DetectedThe page shows a redesigned layout and updated visuals for the Study Details page, but no study data or eligibility content appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check83 days agoChange DetectedAdded a government-status notice and a v3.2.0 revision; removed the v3.1.0 revision. The page now informs users about potential delays and where to check current operating status, and indicates the new version.SummaryDifference6%

- Check90 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.